Recourse Biologics, Inc. — Form D
Recourse Biologics, Inc. of HOUSTON, TX, a company, filed a Form D exempt-offering notice with the SEC on 2024-10-08. The offering totals $4.3M, of which $2.8M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-10-08
- Form: D
- Accession: 0002038107-24-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $4.3M
- Amount sold: $2.8M
- Remaining: $1.5M
- Investors: 14
- Date of first sale: 2024-09-26
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-526186
Issuer
- Name: Recourse Biologics, Inc.
- CIK: 0002038107
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2024
- Address: 3737 BUFFALO SPEEDWAY, HOUSTON, TX, 77098
- Phone: (713) 304-3057
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Alexander Krupnick | Director | Houston, TX |
| Daniel Watkins | Director | Houston, TX |
| John K Westwick | Director | Houston, TX |
| Daniel Watkins | Executive Officer | Houston, TX |
| John K Westwick | Executive Officer | Houston, TX |
More